Accord Healthcare
Accord Healthcare's Overview
Accord Healthcare is a major global pharmaceutical company dedicated to the development, manufacturing, and distribution of a broad portfolio of high-quality, affordable generic pharmaceutical products and biosimilars. With a significant presence in over 85 countries, Accord Healthcare is committed to improving patient access to essential medicines across various therapeutic areas, including oncology, cardiology, neurology, diabetes, and pain management. Accord Healthcare is a subsidiary of Intas Pharmaceuticals Ltd., leveraging its parent company's strong R&D and manufacturing capabilities.
Where is Accord Healthcare's Headquarters?
HQ Function
Serves as a key operational and commercial hub for Accord Healthcare in the UK and Europe, overseeing manufacturing, distribution, sales, marketing, and regulatory compliance for the region.
Notable Features:
The Barnstaple site includes extensive manufacturing facilities, advanced quality control laboratories, and substantial warehousing and distribution capabilities. It is one of the largest pharmaceutical employers in the South West of England.
Work Culture:
The work culture emphasizes quality, innovation in generic medicine, patient focus, and collaboration. It operates under stringent pharmaceutical industry standards, fostering an environment of precision and continuous improvement.
HQ Significance:
The Barnstaple headquarters is crucial for Accord's European strategy, providing a strong manufacturing and supply chain base. It plays a vital role in supplying medicines to the NHS and other European healthcare systems.
Values Reflected in HQ: The headquarters reflects Accord's core values of quality, affordability, accessibility, and a commitment to improving global health outcomes through reliable and efficient operations.
Location:
Accord Healthcare has a robust global presence, operating in over 85 countries across Europe, North America, Latin America, Asia-Pacific, the Middle East, and Africa. Key global functions include R&D, API and finished dosage form manufacturing, quality control and assurance, regulatory affairs, global supply chain management, pharmacovigilance, and extensive commercial operations including sales, marketing, and distribution. This widespread network enables Accord to deliver a diverse portfolio of affordable medicines to patients worldwide.
Street Address:
Whiddon Valley, Sage House
City:
Barnstaple
State/Province:
Devon
Country:
United Kingdom
Accord Healthcare's Global Presence
Durham, North Carolina/USA
Address: 1009 Slater Road, Suite 210-B, Durham, NC 27703, USA
To drive Accord's growth in the North American pharmaceutical market by providing generic and specialty medicines, ensuring compliance with FDA standards, and expanding patient access to affordable treatments.
Ahmedabad, Gujarat/India
Address: Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad - 380054, India
Serves as the core innovation and manufacturing engine for Intas and Accord, leveraging India's pharmaceutical expertise to develop and produce a wide range of medicines for global markets.
Multiple locations across Europe, MENA, Americas, and Asia-Pacific
Address: Various national and regional offices.
To ensure local market presence, tailor strategies to regional healthcare needs, manage local distribution networks, and comply with national regulatory requirements across its extensive operational footprint.
Buying Intent Signals for Accord Healthcare
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Accord Healthcare
As of April 2025, Accord Healthcare' leadership includes:
Investors of Accord Healthcare
Accord Healthcare has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Publicly announced executive new hires or exits specifically for Accord Healthcare are infrequent, which is common for subsidiaries of privately held companies. Leadership appointments are often managed internally or announced at a regional level without widespread press releases. Key leadership roles within Intas Pharmaceuticals, which directly impact Accord, generally show stability.
Technology (Tech Stack) used by Accord Healthcare
Discover the tools Accord Healthcare uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Accord Healthcare Email Formats and Examples
Accord Healthcare commonly uses email formats that combine an employee's name with the company domain '@accord-healthcare.com'. The most prevalent formats are 'first.last' or 'firstinitiallast'. For regional variations, the domain might change (e.g., '@accord-healthcare.co.uk' or '@accord-healthcare.us').
[first].[last]@accord-healthcare.com or [first_initial][last]@accord-healthcare.com
Format
john.smith@accord-healthcare.com or jsmith@accord-healthcare.com
Example
80%
Success rate
News and media
Accord Healthcare Press Release • March 20, 2024
Accord Healthcare Continues European Biosimilar Expansion with YESAFILI® (aflibercept) Launch
Accord Healthcare announced the launch of YESAFILI®, a biosimilar to Eylea® (aflibercept), in major European markets including the UK, Spain, Italy, and Portugal, following its European Commission approval. This launch strengthens Accord's commitment to providing affordable and accessible complex medicines....more
Accord BioPharma Press Release • November 28, 2023
Accord BioPharma Receives FDA Approval for PELgraz® (pegfilgrastim-apgf), a Biosimilar to Neulasta®
Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, announced that the U.S. Food and Drug Administration (FDA) has approved PELgraz® (pegfilgrastim-apgf), its biosimilar to Amgen’s Neulasta®, for patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs....more
Accord Healthcare US Press Release • October 26, 2023
Accord Healthcare Launches IDASUVE® (Naloxone HCl) Nasal Spray 4mg, the First Generic Version of Narcan® Nasal Spray in the US
Accord Healthcare, Inc. announced the U.S. launch of IDASUVE® (Naloxone HCl) Nasal Spray 4mg. IDASUVE® is the first FDA-approved generic equivalent of Narcan® (naloxone hydrochloride) Nasal Spray, 4 mg, and is used for the emergency treatment of known or suspected opioid overdose....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Accord Healthcare, are just a search away.